124 related articles for article (PubMed ID: 38043903)
1. Sole brachytherapy for inoperable, recurrent, and irradiated salivary gland cancer.
Zhong Y; Lyu X; Huang M; Zheng L; Liu S; Shi Y; Wu W; Zhang J; Zhang J
Radiother Oncol; 2024 Jan; 190():110022. PubMed ID: 38043903
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of iodine-125 permanent brachytherapy versus intensity-modulated radiation for inoperable salivary gland malignancies: study protocol of a randomised controlled trial.
Liu SM; Wang HB; Sun Y; Shi Y; Zhang J; Huang MW; Zheng L; Lv XM; Zheng BM; Reilly KH; Yan XY; Ji P; Wu YF; Zhang JG
BMC Cancer; 2016 Mar; 16():193. PubMed ID: 26951097
[TBL] [Abstract][Full Text] [Related]
3. [
Yu HB; Wu WJ; Lv XM; Shi Y; Zheng L; Zhang JG
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):919-923. PubMed ID: 33047730
[TBL] [Abstract][Full Text] [Related]
4. The role of
Huang MW; Wu WJ; Lv XM; Yu GY; Zhang JG
Brachytherapy; 2018; 17(1):244-249. PubMed ID: 29102739
[TBL] [Abstract][Full Text] [Related]
5. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
[TBL] [Abstract][Full Text] [Related]
6. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.
Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809
[TBL] [Abstract][Full Text] [Related]
7. Upfront radiotherapy with brachytherapy for medically inoperable and unresectable patients with high-risk endometrial cancer.
Gannavarapu BS; Hrycushko B; Jia X; Albuquerque K
Brachytherapy; 2020; 19(2):139-145. PubMed ID: 32061534
[TBL] [Abstract][Full Text] [Related]
8. Endoluminal high-dose-rate brachytherapy for locally recurrent or persistent esophageal cancer.
Taggar AS; Pitter KL; Cohen GN; Schattner M; Gerdes H; Markowitz AJ; Ilson D; Brady P; Cuaron JJ; Goodman KA; Wu AJ
Brachytherapy; 2018; 17(3):621-627. PubMed ID: 29496425
[TBL] [Abstract][Full Text] [Related]
9. Salvage re-irradiation in non-melanoma skin cancers: A multicenter analysis.
Miszczyk M; Suleja A; Sobel S; Stec M; Chyrek AJ; Kolbusz M; Spałek M; Nasiek A; Stankiewicz M; Lelek P; Moll M; Kluska A; Kazalski D; Saniewski P; Kaminiów K; Burchardt WM; Wojcieszek P; Chicheł A; Cichoń P; Krzysztofiak T
Radiother Oncol; 2023 Dec; 189():109945. PubMed ID: 37806558
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of a protocol-based ultrasound-guided salvage brachytherapy as re-irradiation for local recurrent prostate cancer.
Schönle N; Strnad V; Lotter M; Kreppner S; Fietkau R
Radiother Oncol; 2020 Sep; 150():201-205. PubMed ID: 32593646
[TBL] [Abstract][Full Text] [Related]
11. Fast neutron radiation for inoperable and recurrent salivary gland cancers.
Koh WJ; Laramore G; Griffin T; Russell K; Griffin B; Parker R; Davis L; Pajak TF
Am J Clin Oncol; 1989 Aug; 12(4):316-9. PubMed ID: 2667321
[TBL] [Abstract][Full Text] [Related]
12. 125I brachytherapy alone for recurrent or locally advanced adenoid cystic carcinoma of the oral and maxillofacial region.
Huang MW; Zheng L; Liu SM; Shi Y; Zhang J; Yu GY; Zhang JG
Strahlenther Onkol; 2013 Jun; 189(6):502-7. PubMed ID: 23625361
[TBL] [Abstract][Full Text] [Related]
13. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate interstitial brachytherapy for the treatment of high-volume locally recurrent endometrial carcinoma.
Huang K; D'Souza D; Patil N; Velker V; Leung E; Stitt L; Whiston F; Sugimoto A; McGee J; Prefontaine M
Brachytherapy; 2016; 15(5):543-8. PubMed ID: 27475479
[TBL] [Abstract][Full Text] [Related]
15. Preliminary results of (125)I interstitial brachytherapy for locally recurrent parotid gland cancer in previously irradiated patients.
Zheng L; Zhang J; Zhang J; Song T; Huang M; Yu G
Head Neck; 2012 Oct; 34(10):1445-9. PubMed ID: 22488812
[TBL] [Abstract][Full Text] [Related]
16. Salvage high-dose-rate brachytherapy for esophageal cancer in previously irradiated patients: A retrospective analysis.
Wong Hee Kam S; Rivera S; Hennequin C; Lourenço N; Chirica M; Munoz-Bongrand N; Gornet JM; Quéro L
Brachytherapy; 2015; 14(4):531-6. PubMed ID: 25906950
[TBL] [Abstract][Full Text] [Related]
17. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
[TBL] [Abstract][Full Text] [Related]
18. Daytime pulsed dose rate brachytherapy as a new treatment option for previously irradiated patients with recurrent oesophageal cancer.
Harms W; Krempien R; Grehn C; Berns C; Hensley FW; Debus J
Br J Radiol; 2005 Mar; 78(927):236-41. PubMed ID: 15730988
[TBL] [Abstract][Full Text] [Related]
19. Endoluminal high-dose-rate brachytherapy for early stage and recurrent esophageal cancer in medically inoperable patients.
Folkert MR; Cohen GN; Wu AJ; Gerdes H; Schattner MA; Markowitz AJ; Ludwig E; Ilson DH; Bains MS; Zelefsky MJ; Goodman KA
Brachytherapy; 2013; 12(5):463-70. PubMed ID: 23434221
[TBL] [Abstract][Full Text] [Related]
20. CT-guided permanent 125I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy.
Yao L; Jiang Y; Jiang P; Wang H; Meng N; Qu A; Tian S; Sun H; Liu C; Wang J; Zhang K
Brachytherapy; 2015; 14(5):662-9. PubMed ID: 26138110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]